Cargando…
Evaluation of BRCA1 and BRCA2 as Indicators of Response to Immune Checkpoint Inhibitors
This cohort study examines the association of BRCA1 and BRCA2 with tumor mutation burden and response to immune checkpoint inhibitors.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105747/ https://www.ncbi.nlm.nih.gov/pubmed/33961040 http://dx.doi.org/10.1001/jamanetworkopen.2021.7728 |
| Sumario: | This cohort study examines the association of BRCA1 and BRCA2 with tumor mutation burden and response to immune checkpoint inhibitors. |
|---|